About Valencell
Valencell is a company based in Raleigh (United States) founded in 2006 by Michael Aumer. Valencell has raised $37.6 million across 21 funding rounds from investors including Halma, HHS and Best Buy. Valencell offers products and services including Fingertip Blood Pressure Monitor and Mobile App. Valencell operates in a competitive market with competitors including Laborie Medical, Aktiia, InvenSense, Epicore Biosystems and Triad Semiconductor, among others.
- Headquarter Raleigh, United States
- Founders Michael Aumer
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Valencell, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37.6 M (USD)
in 21 rounds
-
Latest Funding Round
-
Investors
Halma
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Valencell
Valencell offers a comprehensive portfolio of products and services, including Fingertip Blood Pressure Monitor and Mobile App.
Cuffless tool for accurate blood pressure measurement and tracking.
Application for managing and monitoring user health data effectively.
People of Valencell
Unlock access to complete
Unlock access to complete
Funding Insights of Valencell
Valencell has successfully raised a total of $37.6M across 21 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Last Round
-
First Round
First Round
(14 May 2007)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series E - Valencell | Valuation | Halma | |
| Jun, 2018 | Amount | Series E - Valencell | Valuation | Sonion | |
| Mar, 2016 | Amount | Series D - Valencell | Valuation | Gulf Islamic Investments |
Investors in Valencell
Valencell has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Halma, HHS and Best Buy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are provided by TDF Ventures in US companies.
|
Founded Year | Domain | Location | |
|
Investments in multiple sectors are pursued through PE and VC.
|
Founded Year | Domain | Location | |
|
Venture capital firm supporting AI founders through investments and community.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Valencell
Financial Statements - Valencell
Valencell Comparisons
Competitors of Valencell
Valencell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laborie Medical, Aktiia, InvenSense, Epicore Biosystems and Triad Semiconductor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| domain | founded_year | HQ Location |
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
|
|
| domain | founded_year | HQ Location |
MotionTracking sensor system on chips with integrated motion and sound solutions
|
|
| domain | founded_year | HQ Location |
Wearable sweat-based microfluidic sensing systems are provided for health monitoring.
|
|
| domain | founded_year | HQ Location |
Mixed-signal ASICs for SteamVR sensor arrays are developed and produced.
|
|
| domain | founded_year | HQ Location |
Impact sensors and app are provided for real-time swing analytics.
|
Frequently Asked Questions about Valencell
Valencell was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Valencell is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Kent Novak is the current CEO of Valencell.
Valencell is a funded company, having raised a total of $37.6M across 21 funding rounds to date. The company's 1st funding round was a Series D of $11M, raised on May 14, 2007.
Valencell was founded in 2006 and is headquartered in Raleigh, United States. AI-based medical devices are developed by the company for tracking body vitals, including blood pressure, heart rate, VO2 max, step count, and respiration rate. PPG sensor technology is provided for integration into wearable and hearable products within the health monitoring sector. Operations focus on calibration of multiple health metrics for device manufacturers.
Valencell's top competitors include Epicore Biosystems, Laborie Medical and InvenSense.
Valencell offers Fingertip Blood Pressure Monitor and Mobile App.
Valencell has 9 investors. Key investors include Halma, HHS, Best Buy, Sonion, and TDF Ventures.